کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5561977 1562303 2016 10 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Ketamine alleviates bradykinin-induced disruption of the mouse cerebrovascular endothelial cell-constructed tight junction barrier via a calcium-mediated redistribution of occludin polymerization
ترجمه فارسی عنوان
کتامین باعث کاهش اختلال ناشی از برادیکینین در سلول های مغزی مغز استخوان مغزی می شود که از طریق توزیع مجدد کلسیم توسط پلیمریزاسیون اکولودین
موضوعات مرتبط
علوم زیستی و بیوفناوری علوم محیط زیست بهداشت، سم شناسی و جهش زایی
چکیده انگلیسی


- Ketamine could suppress bradykinin-induced intracellular calcium mobilization.
- Ketamine induced B1R protein and mRNA expressions but did not change B2R protein levels.
- Ketamine attenuated bradykinin-induced redistribution of occludin tight junctions.
- Ketamine prevented bradykinin-induced breakage of the MCEC-constructed tight junction barrier.

Following brain injury, a sequence of mechanisms leads to disruption of the blood-brain barrier (BBB) and subsequent cerebral edema, which is thought to begin with activation of bradykinin. Our previous studies showed that ketamine, a widely used intravenous anesthetic agent, can suppress bradykinin-induced cell dysfunction. This study further aimed to evaluate the protective effects of ketamine against bradykinin-induced disruption of the mouse cerebrovascular endothelial cell (MCEC)-constructed tight junction barrier and the possible mechanisms. Exposure of MCECs to bradykinin increased intracellular calcium (Ca2+) concentrations in a time-dependent manner. However, pretreatment of MCECs with ketamine time- and concentration-dependently lowered the bradykinin-induced calcium influx. As to the mechanisms, although exposure of MCECs to ketamine induced bradykinin R1 receptor protein and mRNA expression, this anesthetic did not change levels of the bradykinin R2 receptor, a major receptor that responds to bradykinin stimulation. Bradykinin increased amounts of soluble occludin in MCECs, but pretreatment with ketamine alleviated this disturbance in occludin polymerization. Consequently, exposure to bradykinin decreased the transendothelial electronic resistance in the MCEC-constructed tight junction barrier. However, pretreatment with ketamine attenuated the bradykinin-induced disruption of the tight junction barrier. Taken together, this study shows that ketamine at a therapeutic concentration can protect against bradykinin-induced breakage of the BBB via suppressing calcium-dependent redistribution of occludin tight junctions. Thus, ketamine has the potential for maintaining the BBB in critically ill patients with severe brain disorders.

135

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Toxicology - Volumes 368–369, 10 August 2016, Pages 142-151
نویسندگان
, , , , , ,